Summary
Results from in vitro works suggest that 1,25- and 24,25-dihydroxyvitamin D3 (1,25-(OH)2D3 and 24,25-(OH)2D3) act on bone via different mechanisms. The present investigation was performed to study the effect of these two metabolites and of their precursor 25-hyxdroxyvitamin D3 (25-(OH)D3) on bone cAMP content in vitro. Rats' paired half calvaria were incubated under sterile conditions with one vitamin D3 derivative (10−13 to 10−9 M) or with ethanol (0.005 ml for 15 min to 24 h in 1 ml medium containing 0, 0.2, 1, 2, or 3 mM calcium. In some experiments: (a) cycloheximide (10−5M) was added simultaneously with the vitamin D3 metabolites; (b) 1–84 bPTH (5 × 10−8 M) was added for 5 or 15 min at the end of the 24 h incubation. Calvaria were immersed in 1 ml TCA 5% 4°C and homogenized. The cAMP was extracted with diethylether and measured by a competitive protein binding assay. Results bring further evidence for a particular effect of low doses of 24,25-(OH)2D3 (10−9 to 10−12M) and of 25-(OH)D3 (10−9 to 10−11M) on bone, different from that of 1,25-(OH)2D3: cAMP content was higher in 24,25-(OH)2D3- or 25-(OH)D3-treated and lower in 1,25-(OH)2D3-treated calvaria than in ethanol-treated ones with 1 mM calcium. The 1,25-(OH)2D3 effect persisted in calcium-free medium whereas 25-(OH)D3 and 24,25-(OH)2D3 effects could not be observed with 0 mM nor with 3 mM calcium. The required duration of the preincubation (over 1 h) as well as the inhibitory action of cycloheximide may suggest an involvement of protein synthesis in the vitamin D3 metabolites effects. Neither 1,25-(OH)2D3 nor 24,25-(OH)2D3 affected the PTH-induced increase in bone cAMP content.
Similar content being viewed by others
References
Chase, L.R., Fedak, S.A., Aurbach, G.D.: Activation of skeletal adenyl cyclase by parathyroid hormone in vitro, Endocrinology84:761–768, 1969
Herrmann-Erlee, M.P.M., Konijn, T.M.: Effect of parathyroid extract on cyclic AMP content of embryonic mouse calvaria, Nature227:177–178, 1970
Chase, L.R., Aurbach, G.D.: The effect of parathyroid hormone on the concentration of adenosine 3′5′-monophosphate in skeletal tissue in vitro, J. Biol. Chem.245:1520–1526, 1970
Raisz, L.G., Trummel, C.L., Holick, M.F., DeLuca, H.F.: 1,25-Dihydroxycholecalciferol: A potent stimulator of bone resorption in tissue culture, Science175:768–769, 1972
Reynolds, J.J., Holick, M.F., DeLuca, H.F.: The role of vitamin D metabolites in bone resorption, Calcif. Tissue Res.12:295–301, 1973
Stern, P.H., Hamstra, A.J., DeLuca, H.F., Bell, N.H.: Bone organ culture bioassay for determination of 1,25-(OH)2D. In A.W. Norman, K. Schaefer, J.W. Cobburn, H.F. DeLuca, D. Fraser, H.G. Grigoleit, and D.V. Herrath (eds.): Vitamin D: Biochemical, Chemical and Clinical Aspects related to Calcium Metabolism, pp. 531–540. Walter de Gruyter, Berlin, 1977
Mellow, A.M., Stosich, G.V., Stern, P.H.: Dissociation of specific binding of 25-(OH)D3 and resorption in fetal rat bones. Mol. Cell. Endocrinol.10:149–158, 1978
Wong, G.L., Luben, R.A., Cohn, D.V.: 1,25-Dihydroxycholecalciferol and parathormone: Effects on isolated osteoclast-like cells, Science197:663–665, 1977
Yamamoto, I., Dokoh, S., Fukunaga, M., Morita, R., Torizuka, K.: Non specific suppression of increase in cyclic AMP in cultured cells after exposure to vitamin D metabolites. In A.W. Norman, K. Schaefer, H.G. Grigoleit, D. Von Herrath, and E. Ritz (eds.): Proceedings of the Fourth Workshop on Vitamin D, Berlin, February 1979, Walter de Gruyter, Berlin (in press)
Lieberherr, M., Garabédian, M., Guillozo, H., Bailly du Bois, M., Balsan, S.: Interaction of 24,25-Dihydroxyvitamin D3 and parathyroid hormone on bone enzymes in vitro, Calcif. Tissue Int.27:47–52, 1979
Dziak, R.: Effects of vitamin D3 metabolites on bone cell calcium transport, Calcif. Tissue Int.26:65–70, 1978
Dziak, R., Stern, P.H.: Calcium transport in isolated bone cells. III. Effects of parathyroid hormone and cyclic 3′5′-AMP, Endocrinology97:1281–1287, 1975
Reynolds, J.J.: The effect of ascorbic acid on the growth of chick bone rudiments in chemically defined medium, Exp. Cell Res.42:178–188, 1966
Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J.: Protein measurement with the Folin phenol reagent, J. biol. Chem.193:265–275, 1951
Gilman, A.G.: A protein-binding assay for adenosine 3′5′-cyclic monophosphate, Proc. Natl. Acad. Sci. U.S.A.67:305–312, 1970
Ramachandran, J.: A new simple method for separation of adenosine 3′5′-cyclic monophosphate from other nucleotides and its use in the assay of adenyl cyclase, Anal. Biochem.43:227–239, 1971
Kream, B.E., Jose, M., Yamada, S., DeLuca, H.F.: A specific high affinity binding macromolecule for 1,25-dihydroxyvitamin D3 in fetal bone, Science197:1086–1088, 1975
Garabedian, M., Lieberherr, M., Nguyen, T.M., Corvol, M.T., Bailly du Bois, M., Balsan, S.: The in vitro production and activity of 24,25-dihydroxycholecalciferol in cartilage and calvarium, Clin. Orthop. Rel. Res.135:241–248, 1978
Beaulieu, E.E.: Cell membrane, a target for steroid hormones, Mol. Cell Endocrinol.12:247–254, 1978
Mahgoub, A., Sheppard, H.: Early effect of 25-hydroxycholecalciferol (25-(OH)D3) and 1,25-dihydroxycholecalciferol (1,25-(OH)2D3) on the ability of parathyroid hormone (PTH) to elevate cyclic AMP of intact bone cells, Biochem. Biophys. Res. Commun.62:901–907, 1975
Peck, W.A., Dowling, J.: Failure of 1,25-dihydroxycholecalciferol (1,25-(OH)2D3) to modify cyclic AMP levels in parathyroid hormone treated and untreated bone cells, Endocrinol. Res. Commun.3:157–166, 1976
Gebauer, U., Fleisch, H.: Effect of 1,25-dihydroxycholecalciferol on adenosine 3′5′-cyclic monophosphate production in calvaria of mice, Calcif. Tissue Res.25:223–225, 1978
Herrmann-Erlee, M.P.M., Gaillard, P.J., Nijweide, P.J.: Studies on the interrelation between the effects of PTE, PGE and 1,25-(OH)2D3 on embryonic bone in vitro, Calcif. Tissue Res. [Suppl.]27:A16, 1979
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lieberherr, M., Garabédian, M., Guillozo, H. et al. In vitro effects of vitamin D3 metabolites on rat calvaria cAMP content. Calcif Tissue Int 30, 209–216 (1980). https://doi.org/10.1007/BF02408630
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02408630